International Urology and Nephrology

, Volume 51, Issue 9, pp 1659–1665 | Cite as

The relationship between vitamin D and inflammatory markers in maintenance hemodialysis patients

  • Ali Veysel KaraEmail author
  • Yasin Emrah Soylu
Nephrology - Original Paper



The aim of this study was to investigate the relationship between vitamin D and novel inflammatory markers in hemodialysis patients.


In total, 129 eligible maintenance hemodialysis patients were enrolled in this cross-sectional study. Patients were divided into two groups according to their serum vitamin D levels. A serum 25-hydroxyvitamin D (25(OH)D) level < 20 ng/ml was identified as vitamin D deficiency and a serum level ≥ 20 ng/ml was identified as normal. The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were calculated from the complete blood cell count. Spearman correlation analysis and both logistic and linear regression analyses were used to define the relationships between the study parameters.


The two groups showed statistically significant differences for gender and for C-reactive protein (CRP) and NLR values (p = 0.017, p = 0.010, and p = 0.013). Age and gender were independently associated with vitamin D deficiency (p = 0.003 and p = 0.030). Serum 25(OH)D levels showed significant but weak inverse correlations with CRP (r = − 0.205, p = 0.020) and with NLR (r = − 0.219, p = 0.013). Serum 25(OH)D levels also showed a significant but very weak correlation with PLR (r = − 0.182, p = 0.039). Serum 25(OH)D levels showed no correlation with mean platelet volume (p = 0.660). Gender was the only variable significantly associated with serum vitamin D levels, as determined by linear regression analysis (p = 0.003).


CRP levels and NLR values were significantly higher in the vitamin D deficiency group. A significant inverse correlation was found between serum vitamin D levels and CRP levels, and NLR and PLR values.


Hemodialysis Inflammation Vitamin D C-reactive protein Neutrophil-to-lymphocyte ratio 


Compliance with ethical standards

Conflict of interest

There is no conflict of interest, and that all the authors have read and approved the manuscript being submitted.


  1. 1.
    Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, Hobbs FD (2016) Global prevalence of chronic kidney disease—a systematic review and meta-analysis. PLoS One 11(7):e0158765. CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V (2015) Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet (London, England) 385(9981):1975–1982. CrossRefGoogle Scholar
  3. 3.
    Wakasugi M, Narita I, Kazama JJ (2016) Mortality trends among Japanese dialysis patients, 1988–2013: a joinpoint regression analysis. Nephrol Dial Transplant 31(9):1501–1507. CrossRefPubMedGoogle Scholar
  4. 4.
    Wanner C, Zimmermann J, Schwedler S, Metzger T (2002) Inflammation and cardiovascular risk in dialysis patients. Kidney Int 61:S99–S102. CrossRefGoogle Scholar
  5. 5.
    De Francisco ALM, Stenvinkel P, Vaulont S (2009) Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness. NDT Plus 2(Suppl_1):i18–i26. CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Eleftheriadis T, Kartsios C, Antoniadi G, Kazila P, Dimitriadou M, Sotiriadou E, Koltsida M, Golfinopoulos S, Liakopoulos V, Christopoulou-Apostolaki M (2008) The impact of chronic inflammation on bone turnover in hemodialysis patients. Ren Fail 30(4):431–437. CrossRefPubMedGoogle Scholar
  7. 7.
    Heidari B (2013) C-reactive protein and other markers of inflammation in hemodialysis patients. Casp J Intern Med 4(1):611–616Google Scholar
  8. 8.
    Jofre R, Rodriguez-Benitez P, Lopez-Gomez JM, Perez-Garcia R (2006) Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol 17(12 Suppl 3):S274–S280. CrossRefPubMedGoogle Scholar
  9. 9.
    Catabay C, Obi Y, Streja E, Soohoo M, Park C, Rhee CM, Kovesdy CP, Hamano T, Kalantar-Zadeh K (2017) Lymphocyte cell ratios and mortality among incident hemodialysis patients. Am J Nephrol 46(5):408–416. CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD (2011) Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 17(1):47–58CrossRefPubMedGoogle Scholar
  11. 11.
    Bilir B, Isyar M, Yilmaz I, Varol Saracoglu G, Cakmak S, Dogan M, Mahirogullari M (2015) Evaluation of neutrophil-to-lymphocyte ratio as a marker of inflammatory response in septic arthritis. Eur J Inflamm 13(3):196–203. CrossRefGoogle Scholar
  12. 12.
    Altunoren O, Akkus G, Sezal DT, Ciftcioglu M, Guzel FB, Isiktas S, Torun GI, Uyan M, Sokmen MF, Sevim HA, Sarısık FN, Senel ME, Erken E, Gungor O (2019) Does neutrophil to lymphocyte ratio really predict chronic kidney disease progression? Int Urol Nephrol 51(1):129–137. CrossRefPubMedGoogle Scholar
  13. 13.
    Ahbap E, Sakaci T, Kara E, Sahutoglu T, Koc Y, Basturk T, Sevinc M, Akgol C, Kayalar AO, Ucar ZA, Bayraktar F, Unsal A (2016) Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in end-stage renal disease. Clin Nephrol 85(4):199–208. CrossRefPubMedGoogle Scholar
  14. 14.
    Pineault J, Lamarche C, Bell R, Lafrance JP, Ouellet G, Leblanc M, Pichette V, Bezzaoucha S, Vallee M (2017) Association of neutrophil-to-lymphocyte ratio with inflammation and erythropoietin resistance in chronic dialysis patients. Can J Kidney Health Dis 4:2054358117735563. CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281. CrossRefPubMedGoogle Scholar
  16. 16.
    Cannell JJ, Grant WB, Holick MF (2014) Vitamin D and inflammation. Dermato-endocrinology 6(1):e983401. CrossRefPubMedGoogle Scholar
  17. 17.
    Guillot X, Semerano L, Saidenberg-Kermanac’h N, Falgarone G, Boissier MC (2010) Vitamin D and inflammation. Jt Bone Spine Revue Du Rhumatisme 77(6):552–557. CrossRefGoogle Scholar
  18. 18.
    Feng X, Lv C, Wang F, Gan K, Zhang M, Tan W (2013) Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 beta -induced RANKL, OPG, TNF alpha, and IL-6 expression in human rheumatoid synoviocyte MH7A. Clin Dev Immunol 2013:160123. CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Haddad Kashani H, Seyed Hosseini E, Nikzad H, Soleimani A, Soleimani M, Tamadon MR, Keneshlou F, Asemi Z (2018) The effects of vitamin D supplementation on signaling pathway of inflammation and oxidative stress in diabetic hemodialysis: a randomized, double-blind, placebo-controlled trial. Frontiers in pharmacology 9:50. CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Jean G, Souberbielle JC, Chazot C (2017) Vitamin D in chronic kidney disease and dialysis patients. Nutrients. CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Mohiuddin SA, Marie M, Ashraf M, Hussein M, Almalki N (2016) Is there an association between vitamin D level and inflammatory markers in hemodialysis patients? A cross-sectional study. Saudi J Kidney Dis Transpl 27(3):460–466. CrossRefPubMedGoogle Scholar
  22. 22.
    Mirchi E, Saghafi H, Gharehbeglou M, Aghaali M, Rezaian Z, Ghaviahd M (2016) Association between 25-hydroxyvitamin D level and inflammatory and nutritional factors in hemodialysis and peritoneal dialysis patients in Qom, Iran. Iran J Kidney Dis 10(4):205–212PubMedGoogle Scholar
  23. 23.
    Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930. CrossRefPubMedGoogle Scholar
  24. 24.
    Katrinaki M, Kampa M, Margioris A, Castanas E, Malliaraki N (2016) Vitamin D levels in a large Mediterranean cohort: reconsidering normal cut-off values. Hormones (Athens, Greece) 15(2):205–223. CrossRefGoogle Scholar
  25. 25.
    Hosmer DW Jr, Lemeshow S, Sturdivant R (2013) Model building strategies and methods for logistic regression. In: Balding DJ, Cressie NAC, Fitzmaurice GM, Goldstein H, Johnstone IM, Malenbergs G, Scott DW, Smith AFM, Tsay RS, Weisberg S (eds) Applied logistic regression, vol 398. Wiley, Hoboken, New JerseyGoogle Scholar
  26. 26.
    Carrero JJ, Stenvinkel P (2010) Inflammation in end-stage renal disease—what have we learned in 10 years? Semin Dial 23(5):498–509. CrossRefPubMedGoogle Scholar
  27. 27.
    Henning BF, Zidek W, Linder B, Tepel M (2002) Mean platelet volume and coronary heart disease in hemodialysis patients. Kidney Blood Press Res 25(2):103–108. CrossRefPubMedGoogle Scholar
  28. 28.
    Henriksen VT, Rogers VE, Rasmussen GL, Trawick RH, Momberger NG, Aguirre D, Barker T (2014) Pro-inflammatory cytokines mediate the decrease in serum 25(OH)D concentrations after total knee arthroplasty? Med Hypotheses 82(2):134–137. CrossRefPubMedGoogle Scholar
  29. 29.
    Adorini L, Penna G (2008) Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 4(8):404–412. CrossRefPubMedGoogle Scholar
  30. 30.
    Akbas EM, Gungor A, Ozcicek A, Akbas N, Askin S, Polat M (2016) Vitamin D and inflammation: evaluation with neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio. Arch Med Sci 12(4):721–727. CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Amer M, Qayyum R (2012) Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol 109(2):226–230. CrossRefPubMedGoogle Scholar
  32. 32.
    Grzanka A, Machura E, Mazur B, Misiolek M, Jochem J, Kasperski J, Kasperska-Zajac A (2014) Relationship between vitamin D status and the inflammatory state in patients with chronic spontaneous urticaria. J Inflamm 11(1):2. CrossRefGoogle Scholar
  33. 33.
    Liefaard MC, Ligthart S, Vitezova A, Hofman A, Uitterlinden AG, Kiefte-de Jong JC, Franco OH, Zillikens MC, Dehghan A (2015) Vitamin D and C-reactive protein: a Mendelian randomization study. PLoS One 10(7):e0131740. CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Department of Nephrology, Faculty of MedicineErzincan UniversityErzincanTurkey
  2. 2.Department of Internal Medicine, Faculty of MedicineErzincan UniversityErzincanTurkey

Personalised recommendations